Taking a New Ingredient to Market: The First 90 Days

Most new ingredients that stall do so after the science works. The data is good, the pilot batch is in the warehouse, and the commercial plan still says "send samples to everyone and see who bites." A go-to-market plan for a new ingredient should decide something in the first 90 days. Who buys first, what they need to see, and what you will stop doing.

Why the first 90 days of a launch decide so much

Ingredient sales cycles are long. A formulator tests your material, the brand runs stability and claims work, procurement negotiates, and the launch slot is set by the customer's calendar. In personal care and food, the time from first sample to first purchase order often runs past a year.

So the projects you open in months one to three are the ones that can turn into revenue in year two. A project opened with the wrong customer or the wrong application takes as long to die as a good one takes to close, and you find out late.

Investors or a parent company will also ask for traction early. Without a plan, the default answer is a count of samples shipped, which looks like progress and predicts very little.

Choosing one application doesn't mean ignoring the others. The mistake I see more often is a team that picks its application, builds the whole story around it, and then can't listen when a customer tests the material and finds it works better somewhere else. Lead with one application, and when a customer pulls you toward another use, follow it up as market information.

Days 1 to 30: choose one application and one buyer

A new ingredient usually has five or six plausible uses. The R&D team has data for some of them, the founder believes in all of them, and every trade show visitor suggests another.

Pick one to lead with. Three questions do most of the work:

1. Where is the performance difference large enough that a formulator will change a working formula for it?
2. Where can the customer pay your price? A premium actives budget in skin care and a commodity line in home care are different conversations.
3. Where is the regulatory path short for the markets you will sell into first?

The answer gives you a beachhead: one application, one customer type (global brand, indie brand, contract manufacturer, or a formulator at another ingredient company), and one or two regions. The other applications wait until the first one has paying customers.

Founders find this step hardest, because it feels like throwing away upside. But a small commercial team can only follow up properly on one front. A team of two cannot run serious projects in cosmetics, food supplements and industrial coatings at the same time.

Days 1 to 30, in parallel: build the kit buyers check first

Before a formulator puts your material in a beaker, someone on their side checks whether it can ever be used. If the documents are missing, the sample sits on a shelf.

For most specialty ingredients, the minimum kit is:

• A product specification with the parameters the customer will test on incoming goods.
• A technical data sheet written for the chosen application, with dosage, compatibility and handling.
• A safety data sheet that matches the target market.
• Regulatory status per region: REACH registration status in the EU, an INCI name for cosmetics, novel food or other food status where relevant, and anything the customer's own compliance team will ask about.
• A clear statement of the claims you can support and the data behind each one.
• Supply facts: current batch size, the realistic scale-up path, lead time, and minimum order quantity.

Then there is price. Early-stage suppliers often hold back pricing until "we know the volume." Buyers read that as either a very high number or a supplier who has not thought about it. You do not need a final price list. You need a price logic: an indicative price at trial volume, what changes at commercial volume, and a cost-in-use calculation at the recommended dosage. Cost-in-use is the number the brand's project manager will take to their own management.

Days 31 to 60: qualify samples before you ship them

Sample requests feel like demand. Many are curiosity, benchmarking against an incumbent, or a student project. Each one still costs material, shipping, documentation and follow-up time.

Before a sample ships, I would want answers to five questions:

• Which product or project is this for?
• Who decides whether it moves forward, and who pays for the next step?
• What does a successful test look like for them, in their own words?
• What is the timeline for their launch or reformulation?
• When will we speak again about the results?

Agree the follow-up date before shipping, and put it in both calendars. A sample with no follow-up date usually disappears into a lab queue.

Qualifying also tells you which channel the customer expects. A large brand may want to buy direct and run the full evaluation in-house. A mid-sized brand may prefer to buy through the distributor it already uses, with local stock and local payment terms. That leads to the next decision.

Direct sales or distributors: decide per region

A new ingredient company rarely has the people to cover every market directly. Decide per region and per customer type, because the choice shapes pricing and who owns the customer relationship.

Direct sales make sense where the first customers are a handful of large accounts, where the technical story needs your own experts in the room, or where the margin cannot carry a distributor's share.

Distributors and agents make sense where buyers expect local stock, local language and consolidated invoicing, or where the customer base is many small and mid-sized brands. A good specialty distributor also brings formulation labs, customer access and credibility you would take years to build.

The mistakes I see most often are signing exclusivity for a large territory before the distributor has shown any results, and signing a distributor without agreeing what they will do in the first six months: which accounts, which events, how many trials. A distribution agreement with no activity plan is an option you gave away for free.

For a startup, a distributor can be one of the best early choices. A good one has years of experience in the market and gives you a second view on how your product performs and how easy it is to work with. They also check your documentation before their customers do, which is industry feedback you get for free. That doesn't mean a distributor everywhere, or a contract you can never leave. Start in the regions where they are strong, and keep the agreement short enough to change course.

Days 61 to 90: turn early interest into a project list you can defend

By the third month the activity should start to show a shape. Some samples came back with results. A few contacts have gone quiet. One or two customers are asking about price at volume, regulatory documents for a second region, or a second test.

This is the point to build a project list, separate from the contact list. A project has a named customer, a named product or formula, a decision maker you have met or can name, a next step with a date, and a rough volume. Everything else is a lead.

For each project, write down the reason it could fail. Common ones:

• The champion at the customer moves to another role, and the successor restarts the evaluation.
• Stability or compatibility issues appear in the final formula.
• The brand's launch is delayed or cancelled for reasons unrelated to you.
• The price works at trial volume but not at the brand's target cost.
• Your own scale-up cannot deliver the commercial quantity on the brand's timeline.

A launch can succeed commercially and then fail on supply. If a customer is planning a launch around your ingredient, the production side needs to know the volume and the date as early as the sales side does.

What to stop doing by day 90

Stop chasing applications outside the beachhead, unless a customer brings a funded project to you. Stop sending samples without the five answers. Stop attending trade shows where your chosen customer type does not walk the floor. And stop reporting samples shipped as the main traction number. Report live projects, their stage, and expected volume instead. Your board will learn more from five qualified projects than from fifty samples.

When you need senior commercial help, and when you don't

If you already have a commercial lead who has launched ingredients into your target market, the plan above is a checklist for them.

Outside help earns its cost when the founding team is technical and has never priced, contracted or distributed an ingredient, when the first commercial hire is junior and needs someone to close the early deals alongside them, or when the company has to decide on distributors and territories it will live with for years.

That is the work I do as a fractional CCO for specialty chemical and ingredient suppliers. I take on the go-to-market directly for a defined period, with the pricing, the first customer conversations and the distributor decisions, and hand over a working setup to the team that stays.

Selling a new specialty ingredient is a contact job. One project runs through R&D, quality, regulatory, procurement and marketing at the customer, and each team has its own priorities and internal politics. Knowing how to move a project through those discussions often decides the price and the terms. I've seen startups with excellent chemistry and no selling experience leave a lot of value on the table at exactly this point.

The 90-day plan in one line

Choose one application, give buyers the documents they check first, ship only qualified samples, settle your channel per region, and finish the quarter with a project list where you know why each project could fail.

If you are planning an ingredient launch and want a second view on the first quarter, you can reach me through opencream.partners.